Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone Matrix Transdermal System in Hypogonadal Men
NCT01323140Phase 2Completed
- Sponsor
- Watson Pharmaceuticals
- Start
- Apr 2011
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of testosterone in Hypogonadism, sponsored by Watson Pharmaceuticals. Primary endpoint: Percent of Subjects With Testosterone Levels in the Normal Range at Day 30. Started Apr 2011; status: completed.
02
Drugs
testosterone
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT01323140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01323140.